相似文献
1
Efonidipine, another beauty relieving the pressure.
Korean Circ J. 2012 Apr;42(4):229-30. doi: 10.4070/kcj.2012.42.4.229. Epub 2012 Apr 26.
2
Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury.
Clin Exp Pharmacol Physiol. 1999 Sep;26(9):674-9. doi: 10.1046/j.1440-1681.1999.03114.x.
3
Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
Clin Exp Hypertens. 2009 Feb;31(1):83-91. doi: 10.1080/10641960802627363.
4
Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
Hypertens Res. 2007 Jul;30(7):621-6. doi: 10.1291/hypres.30.621.
5
Effect of efonidipine, a novel dihydropyridine derivative, on myocardial metabolic changes induced by coronary artery ligation in dogs: comparison with nifedipine.
Fundam Clin Pharmacol. 1997;11(3):245-51. doi: 10.1111/j.1472-8206.1997.tb00192.x.
6
Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
Hypertens Res. 2009 Aug;32(8):670-4. doi: 10.1038/hr.2009.78. Epub 2009 Jun 5.
7
Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
Circ J. 2003 Feb;67(2):139-45. doi: 10.1253/circj.67.139.
8
[Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs].
Nihon Yakurigaku Zasshi. 1996 Nov;108(5):267-74. doi: 10.1254/fpj.108.267.
9
[Effect of efonidipine hydrochloride on myocardial oxygen balance in anesthetized dogs].
Nihon Yakurigaku Zasshi. 1996 Aug;108(2):39-48. doi: 10.1254/fpj.108.39.
10
Structural basis for efonidipine block of a voltage-gated Ca channel.
Biochem Biophys Res Commun. 2019 Jun 4;513(3):631-634. doi: 10.1016/j.bbrc.2019.03.176. Epub 2019 Apr 10.
本文引用的文献
1
Effect of an L- and T-type calcium channel blocker on 24-hour systolic blood pressure and heart rate in hypertensive patients.
Korean Circ J. 2012 Apr;42(4):231-8. doi: 10.4070/kcj.2012.42.4.231. Epub 2012 Apr 26.
2
Beneficial Effect of Efonidipine, an L- and T-Type Dual Calcium Channel Blocker, on Heart Rate and Blood Pressure in Patients With Mild-to-Moderate Essential Hypertension.
Korean Circ J. 2010 Oct;40(10):514-9. doi: 10.4070/kcj.2010.40.10.514. Epub 2010 Oct 31.
3
Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
J Atheroscler Thromb. 2009 Oct;16(5):568-75. doi: 10.5551/jat.1628. Epub 2009 Sep 14.
4
Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate.
J Am Coll Cardiol. 2009 Aug 18;54(8):705-13. doi: 10.1016/j.jacc.2009.02.088.
5
Heart rate as a treatable cardiovascular risk factor.
Br Med Bull. 2009;90:71-84. doi: 10.1093/bmb/ldp016. Epub 2009 May 27.
6
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.
7
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Lancet. 2005;366(9489):895-906. doi: 10.1016/S0140-6736(05)67185-1.
8
Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
Cardiovasc Drug Rev. 2002 Winter;20(1):81-92. doi: 10.1111/j.1527-3466.2002.tb00084.x.
Zotero 插件